A Płużańska

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

Jacek Jassem, Tadeusz Pieńkowski, A Płużańska et al. · Journal of Clinical Oncology · 2001 · 307 citations

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

U. Gatzemeier, A Płużańska, A. Szczęsna et al. · Journal of Clinical Oncology · 2004 · 300 citations

Advanced Nsclc, Oncology, Medicine +14

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group

J Sjöström, Carl Blomqvist, Henning T. Mouridsen et al. · European Journal of Cancer · 1999 · 269 citations

Breast Oncology, Oncology, Anthracycline Failure +7

Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer

Bartłomiej Górski, Tomasz Byrski, Tomasz Huzarski et al. · The American Journal of Human Genetics · 2000 · 257 citations · Full text

Breast Oncology, Somatic Variant, Polish Families +9

An open randomised trial of second-line endocrine therapy in advanced breast cancer

Carsten Rose, O. Vtoraya, A Płużańska et al. · European Journal of Cancer · 2003 · 192 citations

Advanced Breast Cancer, Breast Oncology, Endocrine Oncology +8